NCT02633020
- Conditions
- In-situ Small Bowel T-cell Lymphoma, Type II Refractory Celiac Disease (RCD-II)
- Locations
-
- Clinical Site San Diego, California, United States
- Clinical Site New York, United States
- Clinical Site Tampere, Finland
- Clinical Site Paris, France